Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ehab M Abdelraheem"'
Publikováno v:
BMJ Open Gastroenterology, Vol 7, Iss 1 (2020)
Methods This prospective observatinal study included 128 HCV naive child A cirrhotic patients divided into two groups (77 patients were treated with SOF 400 mg, DACLA 60 mg and ribavirin 600 mg and 51 patients were treated with SOF 400 mg, LDV 90 mg
Externí odkaz:
https://doaj.org/article/e66b4d8b091247bdb92e7cb3187f1bf1
Publikováno v:
The Egyptian Journal of Hospital Medicine. 88:3737-3740
Publikováno v:
The Egyptian Journal of Hospital Medicine. 88:3531-3536
Autor:
Alshymaa A. Hassnine, Mona A. Saber, Yasser M Fouad, Hatem Sarhan, Mahmoud MA Elsayed, Zaki M Zaki, Ehab M Abdelraheem, Safaa M Abdelhalim, Amr M. Elsayed
Publikováno v:
Virus research.
Chronic hepatitis B (HBV) and C virus (HCV) infections represent significant public health issues internationally. HBV vaccination has high sero-conversion rates in patients with mild to moderate chronic liver disease but has reduced efficacy in adva
Autor:
Alshymaa A. Hassnine, Wail Soliman, Amr M. Elsayed, Mahmoud M. Higazi, Mery Saied, Ehab M. Abdelraheem
Publikováno v:
Egyptian Liver Journal. 12
BackgroundLiver cirrhosis (LC) is the most common cause of portal hypertension. In chronic hepatitis C patients who are treated with direct-acting antiviral therapy (DAAS), the progression of cirrhosis can be reversed with treatment. Portal hypertens